December 2017

Gene Versions Matter

Modified versions of genes can be used to predict anti-cancer drug effectiveness. /read more

Light at the End of the Tunnel

UHN vision scientists discover potential neuroprotective treatment for glaucoma. /read more

Seeing into the Future

Researchers identify molecular changes in normal breast cells that are adjacent to cancers. /read more

Mind Over Matter

Fatigue and depression are significant barriers to recovery from a stroke. /read more

Cells that Search and Destroy Cancer

Rare T cells may represent a safe and effective treatment for chemotherapy-resistant leukemia /read more

Cell Therapy in the Fast Lane

New method could be used to coax adult cells into repairing and regenerating damaged tissues. /read more
 
Canada’s Top Research Hospital /read more
Advocating for Research /read more
Minister of Science visits UHN /read more
UHN Scientists Receive CRC Awards /read more
 
About Research at UHN
>1000

Researchers

/all researchers
$316.3M

Funding

/top institutions
0.97M

Square feet

of Space

/our institutes
31

World Firsts

/all UHN firsts
820

Trainees

/UHN trainee life
3,418

Articles

Published

/latest news
Data from /UHN Research Report
Research Spotlight is brought to you by UHN Strategic Research Initiatives Development.
Some images adapted from stock.xchng.ca, Wikimedia Commons and Wikipedia.